Zynex Achieves Compound Pharmacy License Approval in 40th State
Marketwired - Thu Nov 20, 7:57AM CST
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pain creams, announced today that it attained compound pharmacy licensing approval in the state of Iowa, marking its fortieth state approval.
Zynex's (ZYXI) CEO Thomas Sandgaard on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Nov 07, 2:12PM CST
Zynex beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:04AM CST
Zynex Announces Third Quarter 2014 Results
Marketwired - Fri Nov 07, 7:01AM CST
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pain creams, announced today its unaudited financial results for the three and nine months ended September 30, 2014.
Zynex reports November 7
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 8:04AM CST
Zynex Schedules Third Quarter 2014 Earnings Release and Webcast
Marketwired - Fri Oct 31, 3:17PM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it will host the Company's third quarter investor webcast on Friday, November 7 at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time.
Zynex Hires Michael Frabotta as VP of Sales
Marketwired - Thu Oct 16, 7:03AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today the recent hire of Michael Frabotta as Vice President of Sales. Mr. Frabotta is responsible for Zynex Medical's sales organization, promoting electrotherapy and compound pharmacy products throughout the United States.
Zynex Announces Second Quarter 2014 Results
Marketwire - Thu Sep 25, 7:01AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today its unaudited financial results for the three and six months ended June 30, 2014.
Zynex Reschedules Second Quarter 2014 Earnings Release and Webcast to September 25, 2014
Marketwire - Wed Sep 17, 5:34PM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today the date for the Company's second quarter investor webcast has been rescheduled to Thursday, September 25th at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time.
Zynex Schedules Second Quarter 2014 Earnings Release and Webcast
Marketwire - Wed Sep 10, 2:31PM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it will host the Company's second quarter investor webcast on Thursday, September 18th at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time.
Zynex Announces Brian Alleman as Chief Financial Officer
Marketwire - Mon Jul 21, 7:00AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today the appointment of Brian Alleman as its new chief financial officer.
Zynex Achieves Compound Pharmacy License Approval in 36 States
Marketwire - Tue Jul 15, 7:03AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it has attained compound pharmacy licensing approval in seventeen additional states bringing the total to thirty-six approvals.
Zynex Appoints Director of Business Development
Marketwire - Wed Jun 25, 7:02AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics and compound pharmacy, announced the hiring of Steve Siefring as Director of Business Development. Mr. Seifring will be responsible for driving sales activities in the electrotherapy and compound pharmacy business, reporting to Robert Bird, Vice President of Sales in the US.
ZTE, JD.com Sign CNY3.5bn Agreement
SinoCast - Fri Jan 17, 4:48AM CST
ZTE Corporation January 16 signed a CNY 3.5 billion strategic cooperation agreement with JD.com, which showed that the two will jointly launch the Youth mobile phones.
BSX: 13.13 (+0.07), MDT: 74.08 (+0.31), STJ: 66.67 (+0.67), UPI: 2.30 (unch), CYBX: 54.63 (+0.48)